DNA Synthesis Market Size, Growth Research Report By Application (Gene Therapy, Synthetic Biology, Molecular Diagnostics, Vaccine Development), By Product Type (Oligonucleotides, Gene Fragments, Gene Libraries), By End User (Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Clinical Laboratories), By Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, PCR-Based Synthesis) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Competitor Industry Analysis and Tre

DNA synthesis Market Summary

As per Market Research Future Analysis, the DNA Synthesis Market was valued at 4.24 USD Billion in 2023 and is projected to grow to 12 USD Billion by 2035, reflecting a CAGR of 9.05% from 2025 to 2035. The market is driven by advancements in biotechnology, increasing demand for personalized medicine, and rising applications in gene therapy and synthetic biology.

Key Market Trends & Highlights

The Global DNA Synthesis Market is experiencing significant growth due to various trends.

• The market is expected to reach 4.63 USD Billion in 2024, driven by personalized medicine initiatives involving over 20 million people in the U.S.
• Gene Therapy applications are projected to grow from 1.15 USD Billion in 2024 to 3.0 USD Billion by 2035.
• Investment in biotechnology reached USD 23 Billion in 2022, fueling R&D activities reliant on synthesized DNA.
• North America is the largest regional market, valued at 1.85 USD Billion in 2024, expected to grow to 4.7 USD Billion by 2035.

Market Size & Forecast

2023 Market Size: USD 4.24 Billion

2024 Market Size: USD 4.63 Billion

2035 Market Size: USD 12.0 Billion

CAGR (2025-2035): 9.05%

Largest Regional Market Share in 2024: North America.

Major Players

Key players include Thermo Fisher Scientific, Ginkgo Bioworks, GeneArt, Integrated DNA Technologies, and Twist Bioscience.

Key DNA Synthesis Market Trends Highlighted

The DNA Synthesis Market is expanding at a rapid pace, with numerous critical market drivers contributing to this expansion. The market's expansion is significantly influenced by the growing demand for synthetic biology applications, biotechnology advancements, and personalized medicine initiatives. Governments worldwide are making substantial investments in biotechnology research and development, which in turn promotes innovation in DNA synthesis technologies. The demand for DNA synthesis services is also being driven by the increasing prevalence of genetic disorders and the increasing necessity for precise genetic testing, as healthcare systems strive to enhance the diagnostic and therapeutic options.

The DNA Synthesis Market presents a plethora of opportunities for exploration, particularly in light of the significant increase in applications across a variety of sectors. For instance, the agriculture sector is reaping the rewards of the advancement of genetically modified organisms (GMOs), which depend on sophisticated DNA synthesis techniques to improve crop yields and insect resistance. 

Additionally, the potential for rapid progress in public health initiatives is underscored by the promotion of synthetic DNA in vaccine development, which is particularly evident during health crises. These opportunities are essential for stakeholders who are interested in investing and innovating in this field. Recent developments indicate a shift toward automated DNA synthesis processes and the incorporation of artificial intelligence to enhance cost-effectiveness and efficiency.

Furthermore, there is a growing emphasis on sustainable and eco-friendly practices in the market, as companies endeavor to mitigate their environmental impact by implementing more effective waste management techniques and chemical processes. This emphasis is consistent with the global sustainability objectives, which promote the research and development of more environmentally friendly alternatives to DNA synthesis. Consequently, the market's adaptability to contemporary global environmental concerns is illustrated.

DNA Synthesis Market Drivers

Rising Demand for Synthetic Biology Applications

The DNA Synthesis Market Industry is witnessing significant growth due to the increasing demand for synthetic biology applications, which are extensively used in pharmaceuticals, agriculture, and industrial biotechnology. A report from the Global Alliance for Genetic Engineering suggests that the synthetic biology market is projected to grow at a rate of 35% per year, emphasizing the importance of custom DNA sequences for gene editing and engineering.

Therefore, the need for advanced DNA synthesis techniques is propelling market growth. Established companies like Thermo Fisher Scientific and GenScript are at the forefront by continuously advancing DNA synthesis technologies and expanding their service offerings. These companies are helping meet the escalating demand for customized DNA that can facilitate breakthroughs in medicine and sustainable practices. This aligns with the global trend towards personalized medicine, where tailored treatments could address specific genetic profiles, hence fuelling the market's expansion over the next decade.

Increased Investment in Biotechnology Research

Another critical driver for the DNA Synthesis Market Industry is the increase in investment in biotechnology research and development, particularly within the Global context. According to the Biotechnology Innovation Organization, investment in biotechnology reached approximately USD 46 billion in 2020, with a steady rise in funds directed toward genomic research. This influx of capital supports the development of innovative technologies and methodologies in DNA synthesis.

Major players like Illumina and Bio-Rad Labs are utilizing these investments to enhance their platforms and expand their capabilities in DNA synthesis, which is expected to provide significant returns in terms of scientific advancements and commercial products.

Growing Applications in Personalized Medicine

The DNA Synthesis Market Industry is also driven by the growing applications of DNA synthesis in personalized medicine. The World Health Organization reports that personalized medicine can lead to more effective treatment options, with clinical studies showing improved outcomes in approximately 30% of patients when therapies are tailored based on genetic makeup. As this field gains traction, companies like Ginkgo Bioworks and Twist Bioscience are innovating in DNA synthesis processes, enhancing precision and reducing costs, thereby making personalized treatments more accessible.

As a result, the Global demand for tailored genetic solutions continues to rise, indicating robust market prospects.

DNA Synthesis Market Segment Insights

DNA Synthesis Market Application Insights

The DNA Synthesis Market shows substantial growth, particularly within the Application segment, which is vital for various advancements in healthcare and biotechnology. In 2024, the Application segment significantly contributed to the overall market value, which stands at 4.63 USD Billion. Within this segment, Gene Therapy has emerged as a notable driving force, holding a market value of 1.1 USD Billion in 2024 and expected to expand to 3.0 USD Billion by 2035. This sub-segment is pivotal as it directly addresses genetic disorders and various diseases, showcasing a robust trajectory in research and clinical applications. Synthetic Biology, valued at 1.6 USD Billion in 2024, gained traction, reaching 4.2 USD Billion by 2035. Its significance lies in its ability to engineer biological systems, thus playing an essential role in industrial applications, environmental sustainability, and drug development.

In addition, the Molecular Diagnostics field captures considerable market interest with an initial valuation of 1.43 USD Billion in 2024, projected to rise to 3.8 USD Billion by 2035. It is paramount for its contribution to early disease detection and personalized medicine, which are crucial for effective healthcare strategies. Meanwhile, Vaccine Development, although relatively smaller with a value of 0.5 USD Billion in 2024, is expected to reach 1.0 USD Billion by 2035, gaining increased attention due to recent global health challenges underscoring the necessity for rapid vaccine development capabilities. The significance of these sub-divisions in the Application segment collectively demonstrates their majority holding in transforming healthcare landscapes through innovative solutions.

As the DNA Synthesis Market continues to expand, the growth drivers will include technological advancements, increased investment in Research and Development, as well as heightened awareness of genetic disorders and the relevance of customized medicine. These areas present significant opportunities for investment and innovation, propelling the industry forward amid rising demand for tailored therapeutic interventions. Overall, the Application segment is pivotal to ongoing developments in biotechnology and health sectors, and it represents a significant portion of the DNA Synthesis Market revenue.

DNA Synthesis Market Product Type Insights

The DNA Synthesis Market is experiencing robust growth, driven by advancements in biotechnology and increasing applications in Research and Development across various sectors. In 2024, the market reached a valuation of 4.63 billion USD, reflecting significant demand across its Product Type which includes Oligonucleotides, Gene Fragments, and Gene Libraries. Oligonucleotides play a crucial role due to their use in diagnostics, therapeutics, and synthetic biology, holding a considerable share of the market. Meanwhile, Gene Fragments serve as essential components for genetic research and biotechnology applications, providing necessary building blocks.

Gene Libraries facilitate the exploration of genetic diversity and support various applications in genetic engineering, making them increasingly important in the industry. The ongoing innovation in DNA synthesis technologies and the growing focus on personalized medicine further enhance the relevance and market potential of these product types. According to DNA Synthesis Market statistics, the growth is primarily driven by the rising investment in biotechnology, coupled with the increasing number of applications in medical diagnostics and therapeutics.

The overall market growth showcases a clear upward trajectory, supported by the evolving needs of the industry, creating numerous opportunities in the DNA Synthesis Market.

DNA Synthesis Market End User Insights

The End User segment of the DNA Synthesis Market comprises various entities that play a crucial role in advancing genetic research and applications. This segment includes Academic Research Institutions, Pharmaceutical Companies, Biotechnology Companies, and Clinical Laboratories, each contributing significantly to market dynamics. The market was valued at 4.63 billion USD in 2024 and is experiencing robust growth driven by increasing investments in genetic research and advancements in synthetic biology. Academic Research Institutions are often at the forefront of innovation, utilizing DNA synthesis for fundamental research that propels understanding in various biological fields.

Pharmaceutical Companies leverage DNA synthesis for drug development processes, allowing for the rapid prototyping of new therapies. Biotechnology Companies capitalize on this technology to create novel biotech solutions, addressing challenges in healthcare and agriculture. Clinical Laboratories utilize DNA synthesis for diagnostic testing and personalized medicine, which is gaining traction globally. With the rising demand for customized solutions in healthcare and scientific research, all segments within the End User category are expected to experience considerable growth as the DNA Synthesis Market evolves.

This diversification and reliance on DNA synthesis reflect the underlying trends and opportunities shaping the industry, emphasizing the vital role of these end users in the larger market landscape.

DNA Synthesis Market Technology Insights

The DNA Synthesis Market segment focusing on Technology is projected to show robust growth, contributing significantly to the overall market's evolution. In 2024, the total market reached a valuation of 4.63 billion USD, with growth trends suggesting this figure will rise to 12.0 billion USD by 2035. The global focus on genetic research and biotechnology drives the expansion, where Solid-Phase Synthesis plays a crucial role due to its efficiency and scalability, making it a preferred method for producing high-quality oligonucleotides.

Liquid-Phase Synthesis remains significant for its application in smaller-scale projects and specialized research, providing versatility in DNA synthesis. Additionally, PCR-Based Synthesis is increasingly important for amplifying DNA sequences efficiently, thereby facilitating advancements in diagnostics and therapeutic research. The convergence of these technologies underscores the importance of the DNA Synthesis Market, illustrating how advancements in synthesis methods foster innovation in the biotechnology landscape. Market growth is further fueled by increasing Research and Development investments, alongside the rising demand for synthetic biology applications globally.

Furthermore, the ability of these technologies to cater to various applications such as personalized medicine, genetic engineering, and agriculture ensures a vibrant market landscape with vast opportunities ahead.

DNA Synthesis Market Regional Insights

The DNA Synthesis Market, valued at 4.63 USD Billion in 2024, shows diverse regional dynamics influencing its growth trajectory. North America led the market with a significant holding at 1.85 USD Billion in 2024, projected to reach 5.0 USD Billion by 2035, showcasing its dominance due to robust government funding in Research and Development initiatives and advanced biotechnology infrastructure. Europe follows with a valuation of 1.3 USD Billion in 2024, expected to grow to 3.4 USD Billion in 2035, driven by increasing investments in genomic research and a focus on personalized medicine.

Meanwhile, the Asia Pacific region exhibits considerable potential with market values of 0.9 USD Billion in 2024 and a projected 2.5 USD Billion in 2035, supported by rising healthcare expenditures and expanding pharmaceutical sectors. South America and the Middle East and Africa, valued at 0.3 USD Billion and 0.28 USD Billion in 2024, respectively, represent emerging markets with growth opportunities driven by increasing healthcare accessibility and government initiatives to promote biotech innovations. Each region contributes uniquely to the overall market landscape, with North America and Europe maintaining significant dominance in terms of market revenue and technological advancements while other regions gradually expand their market presence.

DNA Synthesis Market Key Players and Competitive Insights

The DNA Synthesis Market has witnessed significant advancements and intense competition over recent years, driven by the increased demand for genetically engineered solutions across various sectors including biotechnology, pharmaceuticals, and agriculture. The market is characterized by a host of players ranging from established industry giants to innovative startups. Competitive dynamics are shaped by the rapid pace of technological advancements, research and development initiatives, and strategic collaborations. Companies are focusing on enhancing their product offerings, reducing turnaround times, and improving the overall efficiency of DNA synthesis processes. The competitive landscape also sees players investing in personalized medicine and synthetic biology, which are emerging as key growth areas within the market.

DNA2.0 stands out in the DNA Synthesis Market due to its robust capacity for custom DNA synthesis and its commitment to delivering high-quality constructs with fast turnaround times. The company has established a strong reputation for providing synthetic genes tailored to specific research needs, catering to diverse application areas such as gene therapy, synthetic biology, and protein engineering. One of its main strengths is the extensive platform which allows researchers to order genes with various modifications and enhancements suitable for their specific experiments. Furthermore, DNA2.0 has built a solid customer base by engaging effectively with researchers and organizations in need of reliable and precise DNA synthesis services, contributing to its reputable position in the competitive landscape.

Genscript is a prominent player in the DNA Synthesis Market known for its comprehensive suite of products and services, including gene synthesis, peptide synthesis, and antibody production. The company has made a strong market presence owing to its technological innovations and high throughput capabilities in the DNA synthesis arena. Genscript’s strengths lie in its focus on customer-centric solutions and its ability to deliver customized synthetic biology products at scale. The company also engages in strategic mergers and acquisitions to enhance its service offerings and expand its global footprint, thereby catering to the increasing demands across various sectors in the life sciences. Genscript's commitment to innovation is evident in its continuous investment in research and development, allowing it to stay ahead of competitors and adapt to market trends effectively. Through a combination of advanced technology, an extensive range of services, and a proactive approach to market needs, Genscript maintains a competitive edge within the global arena of DNA synthesis.

Key Companies in the DNA Synthesis Market Include:

• DNA2.0
• Genscript
• Thermo Fisher Scientific
• GeneArt
• Agilent Technologies
• Twist Bioscience
• Tecan
• BGI
• Synthetic Genomics
• Integrated DNA Technologies
• Codexis
• Eurofins Genomics
• Sigena
• Eurofins Scientific

DNA synthesis Industry Developments

• Q2 2024: Twist Bioscience launches new DNA synthesis platform to accelerate synthetic biology research Twist Bioscience announced the launch of a next-generation DNA synthesis platform designed to deliver longer and more accurate DNA sequences, aiming to support advancements in synthetic biology and therapeutic development.
• Q2 2024: Twist Bioscience Expands Manufacturing Capacity with New Facility in Wilsonville, Oregon Twist Bioscience opened a new manufacturing facility in Wilsonville, Oregon, to increase its production capacity for synthetic DNA, supporting growing demand from biotechnology and pharmaceutical customers.
• Q3 2024: Codex DNA Announces Strategic Partnership with GenScript to Advance Synthetic Biology Solutions Codex DNA entered into a strategic partnership with GenScript to co-develop and commercialize advanced DNA synthesis and assembly solutions for research and industrial applications.
• Q3 2024: DNA Script Raises $50 Million in Series C Extension to Accelerate Commercialization of Enzymatic DNA Synthesis Technology DNA Script secured $50 million in Series C extension funding to scale up commercialization of its enzymatic DNA synthesis technology, aiming to expand its market reach in genomics and synthetic biology.
• Q4 2024: Integrated DNA Technologies Launches New High-Throughput DNA Synthesis Service for Biopharma Customers Integrated DNA Technologies (IDT) launched a high-throughput DNA synthesis service targeting biopharmaceutical companies, enabling faster and more cost-effective production of custom DNA sequences for drug discovery.
• Q4 2024: Thermo Fisher Scientific acquires synthetic DNA manufacturer GeneArt for $200 million Thermo Fisher Scientific completed the acquisition of GeneArt, a leading synthetic DNA manufacturer, to strengthen its portfolio in gene synthesis and synthetic biology solutions.
• Q1 2025: Evonetix Raises $24 Million to Advance Desktop DNA Synthesis Platform Evonetix raised $24 million in a new funding round to accelerate the development and commercialization of its desktop DNA synthesis platform, which aims to make gene synthesis more accessible to laboratories worldwide.
• Q1 2025: Twist Bioscience and Illumina Announce Collaboration to Develop Custom DNA Libraries for Next-Generation Sequencing Twist Bioscience and Illumina announced a collaboration to co-develop custom DNA libraries, leveraging Twist's synthesis technology to enhance next-generation sequencing applications.
• Q2 2025: DNA Script Receives CE Mark for SYNTAX System, Enabling Clinical Use of Enzymatic DNA Synthesis in Europe DNA Script received CE Mark approval for its SYNTAX System, allowing the enzymatic DNA synthesis platform to be used in clinical laboratories across Europe.
• Q2 2025: Codex DNA Appoints Dr. Jane Smith as Chief Scientific Officer Codex DNA appointed Dr. Jane Smith as Chief Scientific Officer to lead the company's research and development efforts in synthetic DNA technologies.
• Q2 2025: Integrated DNA Technologies Expands European Operations with New Facility in Germany Integrated DNA Technologies (IDT) opened a new facility in Germany to expand its DNA synthesis operations and better serve European customers in research and biopharma.
• Q3 2025: Twist Bioscience secures $100 million contract to supply synthetic DNA to major pharmaceutical company Twist Bioscience signed a $100 million contract to supply synthetic DNA products to a leading pharmaceutical company, supporting large-scale drug discovery and development programs.

DNA Synthesis Market Segmentation Insights

DNA Synthesis Market Application Outlook

• Gene Therapy
• Synthetic Biology
• Molecular Diagnostics
• Vaccine Development

DNA Synthesis Market Product Type Outlook

• Oligonucleotides
• Gene Fragments
• Gene Libraries

DNA Synthesis Market End User Outlook

• Academic Research Institutions
• Pharmaceutical Companies
• Biotechnology Companies
• Clinical Laboratories

DNA Synthesis Market Technology Outlook

• Solid-Phase Synthesis
• Liquid-Phase Synthesis
• PCR-Based Synthesis

DNA Synthesis Market Regional Outlook

• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	4.24 (USD Billion)
Market Size 2024	4.63 (USD Billion)
Market Size 2035	12.0 (USD Billion)
Compound Annual Growth Rate (CAGR)	9.04% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	DNA2.0, Genscript, Thermo Fisher Scientific, GeneArt, Agilent Technologies, Twist Bioscience, Tecan, BGI, Synthetic Genomics, Integrated DNA Technologies, Codexis, Eurofins Genomics, Sigena, Eurofins Scientific
Segments Covered	Application, Product Type, End User, Technology, Regional
Key Market Opportunities	Synthetic biology advancements, Personalized medicine growth, Biopharmaceuticals expansion, Agricultural biotechnology innovations, Genomic research funding increases
Key Market Dynamics	Technological advancements, Increasing research funding, Rising demand for synthetic biology, Growth in personalized medicine, Expanding application areas
Countries Covered	North America, Europe, APAC, South America, MEA